Shanghai Haohai Biological Technology Co., Ltd. (FRA:5HB)
Germany
· Delayed Price · Currency is EUR 2.940
+0.020 (0.68%)
At close: Dec 5, 2025
FRA:5HB Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 1,240 | 1,660 | 2,038 | 1,971 | 2,621 | 1,747 | Upgrade
|
| Market Cap Growth | -32.61% | -18.56% | 3.36% | -24.80% | 50.05% | -3.06% | Upgrade
|
| Enterprise Value | 1,009 | 1,401 | 1,787 | 1,683 | 2,300 | 1,423 | Upgrade
|
| Last Close Price | 2.94 | 3.11 | 2.98 | 2.81 | 3.47 | 2.94 | Upgrade
|
| PE Ratio | 26.96 | 29.83 | 38.38 | 80.52 | 53.77 | 60.64 | Upgrade
|
| PS Ratio | 4.14 | 4.68 | 6.06 | 6.91 | 10.82 | 10.54 | Upgrade
|
| PB Ratio | 1.76 | 2.12 | 2.65 | 2.46 | 3.13 | 2.43 | Upgrade
|
| P/TBV Ratio | 2.29 | 2.73 | 3.43 | 3.24 | 4.04 | 2.97 | Upgrade
|
| P/FCF Ratio | 27.57 | 44.10 | 43.30 | - | 265.24 | 192.78 | Upgrade
|
| P/OCF Ratio | 17.41 | 19.34 | 25.17 | 62.83 | 55.33 | 53.24 | Upgrade
|
| EV/Sales Ratio | 3.34 | 3.95 | 5.31 | 5.90 | 9.49 | 8.58 | Upgrade
|
| EV/EBITDA Ratio | 17.78 | 19.29 | 24.77 | 36.18 | 50.04 | 55.13 | Upgrade
|
| EV/EBIT Ratio | 31.71 | 28.46 | 35.74 | 75.49 | 84.37 | 122.46 | Upgrade
|
| EV/FCF Ratio | 22.42 | 37.23 | 37.96 | - | 232.66 | 157.06 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.08 | 0.07 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.88 | 0.78 | 0.69 | 0.32 | 0.30 | 0.48 | Upgrade
|
| Debt / FCF Ratio | 1.10 | 1.58 | 1.11 | - | 1.48 | 1.49 | Upgrade
|
| Asset Turnover | 0.35 | 0.38 | 0.38 | 0.30 | 0.26 | 0.21 | Upgrade
|
| Inventory Turnover | 1.56 | 1.66 | 1.56 | 1.56 | 1.61 | 1.35 | Upgrade
|
| Quick Ratio | 3.14 | 3.57 | 4.35 | 5.76 | 6.78 | 7.98 | Upgrade
|
| Current Ratio | 3.77 | 4.22 | 5.24 | 6.91 | 7.62 | 8.78 | Upgrade
|
| Return on Equity (ROE) | 5.95% | 6.30% | 6.92% | 3.18% | 5.89% | 3.98% | Upgrade
|
| Return on Assets (ROA) | 2.28% | 3.27% | 3.50% | 1.48% | 1.86% | 0.93% | Upgrade
|
| Return on Capital (ROIC) | 2.57% | 3.64% | 3.94% | 1.69% | 2.05% | 1.00% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.30% | 5.90% | 6.10% | 2.60% | 3.00% | 1.60% | Upgrade
|
| Earnings Yield | 3.71% | 3.35% | 2.60% | 1.24% | 1.86% | 1.65% | Upgrade
|
| FCF Yield | 3.63% | 2.27% | 2.31% | -0.54% | 0.38% | 0.52% | Upgrade
|
| Dividend Yield | 4.09% | 4.26% | 2.19% | 1.38% | 1.99% | 1.52% | Upgrade
|
| Payout Ratio | 52.01% | 61.80% | 16.46% | 67.54% | 24.96% | 53.92% | Upgrade
|
| Buyback Yield / Dilution | -43.49% | 1.77% | 30.24% | 1.46% | 0.62% | -8.72% | Upgrade
|
| Total Shareholder Return | -39.40% | 6.03% | 32.42% | 2.83% | 2.62% | -7.20% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.